Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
909eTiP Open-label phase II trial of AMB-05X for patients with ctDNA(+) colorectal cancer after curative-intent treatment
2025
0 citations
Journal Article
Field-Weighted Citation Impact:
0.00
Kaysia Ludford
·
The University of Texas MD Anderson Cancer Center
Ryan Huey
·
The University of Texas MD Anderson Cancer Center
Jason Willis
·
The University of Texas MD Anderson Cancer Center
Maria Pia Morelli
·
PaxVax (United States)
D. Nguyen
·
PaxVax (United States)
Kristen Johnson
·
PaxVax (United States)
L. Alani
·
PaxVax (United States)
John Paul Shen
·
The University of Texas MD Anderson Cancer Center
Christine M. Parseghian
·
The University of Texas MD Anderson Cancer Center
Kanwal Raghav
·
PaxVax (United States)
Michael J. Overman
·
The University of Texas MD Anderson Cancer Center
N.A. Dasari
·
The University of Texas MD Anderson Cancer Center
Scott Kopetz
·
The University of Texas MD Anderson Cancer Center
Van K. Morris
·
The University of Texas MD Anderson Cancer Center
909eTiP Open-label phase II trial of AMB-05X for patients with ctDNA(+) colorectal cancer after curative-intent treatment | Researchclopedia